Area of research
Molecular Biology · Oncology
Research interest
Research focused on Multiple myeloma and Gene knockdown, with related work in Messenger RNA, Apoptosis, Flow cytometry. Notable publications include 'miR-26b-5p suppresses proliferation and promotes apoptosis in multiple myeloma cells by targeting JAG1', 'HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma', and 'Enhanced antitumor effect of combination of annexin A1 knockdown and bortezomib treatment in multiple myeloma in vitro and in vivo'.
The association between NADPH oxidase (NOX) polymorphisms with immunohistochemistry and survival in diffuse large B cell lymphoma patients
Prognostic marker CD27 and its micro-environmental in multiple myeloma
Correction: HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma
HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma
Additional file 4 of HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma
Additional file 2 of HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma
Additional file 3 of HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma
Proteomics-Based Approach Reveals the Involvement of SERPINB9 in Recurrent and Relapsed Multiple Myeloma
Significance of the microRNA‑17‑92 gene cluster expressed in B‑cell non‑Hodgkin's lymphoma
miR-26b-5p suppresses proliferation and promotes apoptosis in multiple myeloma cells by targeting JAG1
Enhanced antitumor effect of combination of annexin A1 knockdown and bortezomib treatment in multiple myeloma in vitro and in vivo
Abnormal vascular endothelial growth factor protein expression may be correlated with poor prognosis in diffuse large B-cell lymphoma: A meta-analysis